FDA Approves Vepdegestrant for ER+/HER2–, ESR1-Mutated Breast Cancer: A New Targeted Option
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 6, 2026.
Breast cancer treatment continues to evolve with adva...
First-Line Palbociclib Combination Boosts PFS in HR+/HER2+ mBC – PATINA Findings
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 1, 2026.nnMetastatic breast cancer (mBC) remains a major...
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026.
Advancements in breast cancer treatment continue t...
Healing After Radiation: Is a Nipple-Sparing Mastectomy Possible?
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 20, 2026.nnFor many years, patients who had previously u...
Oral SERDs Explained: The New Hormone Therapy Option After Endocrine Resistance in HR+ Breast Cancer
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 25, 2026.nnHormone receptor-positive, HER2-negative b...
Does Ribociclib Still Help After 3 Years? The NATALEE Trial’s 4-Year Follow-Up Answers
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 21, 2026.nnFor patients with hormone receptor–positiv...
New CDK4/6 Strategies in HR+/HER2– Breast Cancer: Imlunestrant ± Abemaciclib and the Avutometinib Triplet
n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 20, 2026.nnHormone receptor–positive, HER2-negative (...
Can Men Get Breast Cancer? Symptoms and Causes
Most people think of breast cancer as something that only affects women, but it’s important to know that men can get breast cancer too....
HER2 Status in Breast Cancer: Understanding Positive, Negative, and Low Types
Breast cancer comes in many forms—it's not the same for everyone. The disease varies a lot based on biology and m...